(1) |
use by the originator of the notes for treatment;
|
(2) |
use or disclosure for mental health training programs under supervision within the
IHS facility;
|
(3) |
use or disclosure by the
IHS in a legal action or other proceedings brought by the patient, in consultation with Office of the General Counsel; and
|
(4) |
use or disclosure that is required by law, authorized disclosure to a health oversight authority with respect to the oversight of the originator of the psychotherapy notes, or use to report a serious and imminent threat to the health and safety of the patient or a third party;
|
(5) |
disclosure required by the Secretary, Health and Human Services, Department of Health and Human Services, to investigate IHS facility compliance with the Health Insurance Portability and Accountability Act Privacy Rule;
|
(6) |
disclosures to medical examiners or coroners about deceased patients to determine identity, cause of death, or to perform other duties as authorized by law.
|